CareCloud reported second quarter 2026 financial results, with revenue increasing 16% to $31.9 million from $27.4 million in the prior year period. GAAP net income declined to $1.1 million from $2.9 million, resulting in a GAAP EPS of $0.00 compared to $0.04 previously. Adjusted EBITDA fell to $5.9 million from $6.5 million. The company completed the redemption of all outstanding Series B Preferred Stock on May 15, 2026, and acquired Empower Healthcare & Compliance Partners to expand its compliance offerings. Management reaffirmed full-year 2026 guidance for revenue between $128 million and $132 million and adjusted EBITDA between $29 million and $31 million. CareCloud operates in the healthcare technology industry, providing AI-powered revenue cycle management and practice management solutions.

CareCloud, Inc. announced on July 22, 2026, that Executive Chairman Mahmud Haq and two associated trusts entered into a Securities Account Pledge Agreement and a Securities Account Control Agreement with Citizens Bank, N.A. to provide additional collateral support for the company's $40 million term loan and $10 million revolving credit facility. As a result of the pledge of 4,300,000 shares of common stock, the company issued a warrant to Mr. Haq to exercise 4,300,000 shares at a $5.00 per share strike price over a five-year term. CareCloud, Inc. is a healthcare technology company providing cloud-based software solutions for medical practices and healthcare providers.

CareCloud, Inc. entered into a First Amendment to its Credit Agreement with Citizens Bank, N.A. and other lenders, effective May 6, 2026. The amendment modifies information and notice requirements for permitted acquisitions and revises the liquidity condition for such acquisitions, while also extending the deadline for delivering certain securities account pledge documentation to 105 days post-closing. CareCloud, Inc. provides cloud-based software solutions for the healthcare industry.